Latest News

  • NATROX® features at the New NHS Alliance Annual Conference at the King’s Fund in London

    In a communications initiative with New NHS Alliance & ITN Productions, Inotec AMD was featured in their campaign to promote “Healthy Communities, Healthy People’.

    https://itnproductions.wistia.com/medias/vnvlkkz8nf

    New NHS Alliance (www.nhsalliance.org) is a value-led movement of people and organisations who are committed to building a sustainable, community-based health service. It is expanding beyond its core roots in general practice and primary care to embrace people and organisations that can make a positive difference to people’s health and wellbeing. It is focused on heath inequalities and the practice of health creation. It wants to see primary care establish strong connections and collaborations with organisations that make a positive difference to people’s health and wellbeing and become a strong enabler of people-led health improvement.

    More >
  • NATROX® receives Health Canada regulatory approval

    Inotec AMD is pleased to announce that NATROX Continuous Diffusion of Oxygen Therapy has received Health Canada regulatory approval.

    With approval now in hand, Inotec AMD, in partnership with our Canadian national distributor The Stevens Company, will be launching NATROX into the Canadian wound and skin care marketplace. In addition to patient evaluations currently being set up in the Acute Care, Home Care and Long Term Care sectors across Canada, further research on NATROX is also being initiated.

    More >
  • NATROX® promoted at the French CPC Wound Conference 18th to 21st January 2015

    Following their launch of NATROX in France during 2014, Chirurgie Ouest presented Continuous Diffusion of Oxygen Therapy at the CPC Wound Conference (Conférence des Plaies et Cicatrisations) held annually in Paris.

    Attracting approximately 4000 clinicians, the exhibition booth was very busy with great interest from participants, keen to understand and use the healing power of oxygen in wound treatment.

    More >

More News

Inotec AMD awarded a £1million contract from NHS England to further develop NATROX®
More >
NATROX® introduced to over 200 clinical staff in Hong Kong
More >
Academic Poster presented at Wounds UK in November 2014
Addenbrooke’s Hospital in Cambridge and St George’s in London jointly carried out a 6-month case study...
More >
NATROX® highlighted at the Trans Borneo Wound Care Conference
NATROX® was exhibited at the Trans Borneo Wound Conference in Kuching in August 2014
More >